Zimbabwe approves Covaxin, first in Africa to okay India-made Covid-19 vaccine | World News - Hindustan Times
close_game
close_game

Zimbabwe approves Covaxin, first in Africa to okay India-made Covid-19 vaccine

By | Written by Karan Manral, New Delhi
Mar 04, 2021 06:31 PM IST

The Indian embassy in Zimbabwe tweeted the announcement on Thursday. On March 3, Hyderabad-based Bharat Biotech International Limited, which has developed the shot, announced that it was 81% effective against coronavirus.

The Indian embassy in Zimbabwe announced on Thursday the African country has approved the made-in-India vaccine against the coronavirus disease (Covid-19), Covaxin, becoming the first country in the continent to approve the shot developed by Bharat Biotech International Limited.

“Zimbabwe has authorized use of COVAXIN, India’s indigenous COVID-19 vaccine, becoming the first country in Africa to do so. Trying to get it to Zimbabwe at an early date,” the embassy, located in Zimbabwe’s capital city of Harare, tweeted.

Hindustan Times - your fastest source for breaking news! Read now.


The development comes a day after Hyderabad-based Bharat Biotech announced that Covaxin has an efficacy rate of 81%, based on preliminary results from its phase 3 clinical trials. Covaxin, India’s first and so far the only homemade shot against the viral disease, found itself at the centre of a controversy in January, when it was one of the two vaccines cleared by the Drugs Controller General of India (DCGI) for the country’s vaccination drive, which began on January 16.

Also Read | Covaxin has 81% efficacy, says Bharat Biotech: What does it mean

It was alleged that Covaxin was given approval for use without the completion of its phase 3 trials. The other, Oxford University-AstraZeneca’s vaccine, was last year found to be more than 70% effective against the disease. Pune-based Serum Institute of India (SII) is manufacturing Oxford University-AstraZeneca vaccine as Covishield in the country.

Also Read | Concerns over Covaxin as some cite ‘lack of data’

On Monday, when the second phase of the vaccination drive commenced, Prime Minister Narendra Modi was administered his first dose of the Covid-19 vaccine. PM Modi chose to be administered a shot of Covaxin to clear the hesitancy surrounding it; second dose will be administered after 28 days.

Also Read | PM Narendra Modi gets Bharat Biotech’s Covaxin as India expands drive

Under its ‘Vaccine Maitri’ initiative, India has been sending consignments of vaccine doses to several countries. However, the doses being dispatched are of Covishield. Last month, Bharat Biotech had sought approval for Covaxin in more than 40 countries.

Also Read | Bharat Biotech seeks Covid-19 vaccine approval in over 40 countries

According to Johns Hopkins University, Zimbabwe, which has a population of more than 14 million, has recorded 36,179 Covid-19 cases thus far. The related death toll here stands at 1,478.

Unlock a world of Benefits with HT! From insightful newsletters to real-time news alerts and a personalized news feed – it's all here, just a click away! - Login Now!

Get Latest World News along with Latest News from India at Hindustan Times.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, March 28, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On